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induced a 10 fold or greater upregulation of several proinﬂammatory
genes, including cytokines Il-1b, Il-6, Il-8, Il-12, Il-17, and mediators,
COX-2, iNOS, MMP-1, MMP-3, MMP-4, MMP-7, MMP-9, MMP-13. How-
ever, these genes were expressed at negligible to very low density
in unstimulated control chondrocytes. Cluster analysis of chondrocytic
genes in response to low/physiological DTF showed that these signals
markedly regulate genes associated with chondrocyte growth and pro-
liferation, BMP-2, SOX-9, GDF-5, TGF-b, BMP-4, BMP-7, IGF-1, IGF-2;
genes associated with cartilage extracellular matrix, proteoglycans and
collagens, apoptosis, cell cycle associated genes, signaling cascades,
MAP kinases, NF-kB cascade, SMADs, and intracellular structural pro-
teins (actin, tubulin, vimentin, etc), adhesion molecules.
Conclusions: The results demonstrate that mechanical signals dynami-
cally cause complex magnitude-dependent gene regulation. Certain gene
clusters or representative genes are distinct, whereas others overlap in
response to low or high magnitudes of DTF. This differential magnitude-
dependent gene regulation may play a key role to ultimately allow the
remarkable and beneﬁcial/detrimental effects of mechanical signals that
are realized at cartilage level.
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Purpose: KBD) is an endemic osteoarthropathy which is mainly charac-
terised by the degeneration and necrosis of hyaline articular cartilage. At
present the etiology and pathogenesis of KBD is unclear. The aim of this
study was to investigate the expression of proteoglycan, hyaluronic acid
(HA) receptor CD44 and other factors that regulate cartilage metabolism
using the chondrocytes and tissue grafts cultured under in vitro conditions
that mimic some of the etiological factors that are thought to be involved
in the pathogenesis of KBD.
Methods: Different concentrations of mycotoxins suspected as etiological
factors causing KBD; i.e. nivalenol (NIV), deoxynivalenol (DON), T-2
toxin, butenolide (BUT) and moniliformin (MON), and Selenium (Se)
which is thought to abrogate KBD pathology, were added at physio-
logical concentrations to cultured chondrocytes and artiﬁcial cartilage
grafts in vitro to establish models of cartilage degeneration and necrosis
similar to that found with KBD. In addition, cartilage tissue and blood
samples were collected from KBD patients. RT-PCR was used to detect
the mRNA expression of CD44, HA synthase (HAS), aggrecan, aggre-
canases, matrix metalloproteinases (MMP) and tissue inhibitor of metallo-
proteinases (TIMPs). Corresponding protein expression was determined
using Western blot analyses. Immunohistochemistry was used to study
the effects of the mycotoxins on cartilage extracellular matrix metabolism;
i.e. neoepitopes for matrix proteinase degradation (BC-3/BC-13 & BC-
4/BC-14) and CD44. ELISAs were used to quantify Il-1b, TNF-a, MMPs,
soluble CD44 and HA levels in the culture media and KBD patient serum.
Results: A decrease of chondrocyte density and a gradual increase in
chondrocyte degeneration and necrosis were observed with the increase
of mycotoxin concentrations. Se addition partially alleviated this carti-
lage degradation, but did not change the overall trend of degenerative
changes. mRNA expression of aggrecan, TIMP-1 and -3 decreased whilst
that of CD44, HAS, aggrecanase-1 and -2, and MMPs increased in
chondrocytes cultured with the mycotoxins; Se addition showed some
changes. Extracellular matrix staining for cartilage aggrecan became
weak and non-uniform but after Se addition this matrix staining improved.
The expression of aggrecan speciﬁc degradation neoepitopes in cartilage
matrix increased in the presence of the mycotoxins, and this was reduced
after Se addition. The expression of CD44 on the chondrocyte cell
membranes decreased and that in matrix increased in the presence
of the toxins. The levels of glucuronic acid, soluble CD44 and HA in
cell culture media increased gradually with the increase of mycotoxin
concentration. After Se addition, the levels of glucuronic acid showed a
decrease, but that of soluble CD44 levels did not change. The levels of
Il-1b and TNF-a in the culture media of the toxin groups were higher than
Control groups.
Conclusions: These in vitro studies have exposed chondrocyte and
cartilage graft cultures to conditions of mycotoxin exposure that mimic
those believed to be involved in the etiology of KBD patient pathology.
Our results indicate that many of the pathogenic and degradation changes
observed in KBD patients are expressed in these model in vitro culture
systems including the abrogation of some of these effects by adding
Selenium.
Clinical Aspects/Outcomes
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Purpose: Topical treatment of painful muscular and joint complaints with
comfrey root ointment has often been questioned in terms of efﬁcacy.
However, several randomised controlled trials (RCT) impressively showed
the efﬁcacy and safety in blunt injuries and muscle pain of the back. Most
recent data conﬁrmed even superiority versus topical diclofenc in acute
unilateral ankle sprains. However, more clinical trials were demanded to
prove the efﬁcacy in further painful disorders, like osteoarthritis.
The aim of this study was to demonstrate the therapeutic efﬁcacy and
safety of a comfrey root extract ointment (Extr. Rad. Symphyti) in the
treatment of patients with painful osteoarthritis of the knee.
Methods: This randomised, double-blind, placebo-controlled study was
performed in accordance with the Declaration of Helsinki/Hong Kong
1989/Somerset 1996 as well as ICH-GCP Guidelines. 220 patients
(153 women, 67 men, mean age 57.9 years) daily received 6 g (3×2g)
of either an active ointment (Kytta-Salbe® f, containing comfrey root ﬂuid
extract 1:2, 35.0 g) or a corresponding placebo, for 21 days.
The active ointment is available in Germany and Switzerland as a Phar-
macy (P) OTC drug and in the UK on the General sales list (GSL). Pain,
stiffness and functional impairment are the important symptoms patients
seek to relieve. Therefore, the primary target variable was the Visual
Analog Scale (VAS) sum score of pain at rest and pain on movement.
Secondary target variable was the Western Ontario and McMaster Uni-
versities (WOMAC) score.
All patients met the criteria of the American College of Rheumatology.
Baseline characteristics were compared and a statistical analysis was
performed and veriﬁed that there was no statistical difference between
the verum and the placebo group.
Results: In the course of the study, the VAS sum score (primary target
variable) decreased by 51.6mm (54.7%) in the active therapy group and
by 10.1mm (10.7%) in the placebo group. The mean group difference of
41.5mm or 44.0% points was signiﬁcant (p< 0.001).
The WOMAC percentage sum score (secondary target variable) also
decreased strongly. At the end of the study, a reduction by 60.4mm
(58.0%) was observed in the active therapy group and by 14.7mm
(14.1%) in the placebo group. The mean group difference of 45.7mm
or 43.9% points was signiﬁcant (p< 0.001).
With regard to the exploratory target variables SF-36 (quality of life), angle
measurement (knee mobility), CGI (clinical global impression) and global
efﬁcacy assessment by investigator and patient, again a signiﬁcant supe-
riority was demonstrated (p< 0.001, respectively) for the phytotherapeutic
agent versus placebo. 7 patients of the active therapy group were rated
as, no longer requiring treatment.
Conclusions: The verum reduced the symptoms of osteoarthritis of the
knee signiﬁcantly. The therapy lead to reduction of pain, improved knee
mobility and better quality of life. Therefore, the present clinical trial has
demonstrated that the topical application of a comfrey root extract is a
sensible and safe treatment option for patients with painful osteoarthritis.
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Purpose: To assess the prognostic value of the clinical ACR classiﬁcation
criteria of knee osteoarthritis (OA) in general practice.
Methods: Patients consulting for non-traumatic knee complaints in gen-
eral practice aged >35 years were enrolled in the study. At baseline and
during one year follow-up knee complaints and function was assessed
by 3-monthly questionnaires. A physical examination was performed at
baseline and after one year follow-up. The prognostic value of fulﬁlling the
